This site is intended for health professionals only
Wednesday 28 September 2016
Share |

Generic drugs drive undermines NICE cholesterol targets

Tough cholesterol targets will be impossible to hit unless GPs ignore a new benchmark demanding 77% of drugs used to treat it are generic, a new analysis concludes.

The research suggests the new National Institute for Clinical Excellence (NICE) targets for secondary prevention will only be feasible if high-dose or high-potency statins are given to a substantial proportion of patients.

Chasing the targets risks breaking budgets for drugs and raising the number of patients who suffer statin-induced side-effects, the University of Hertfordshire researchers concluded.

They observed 5,800 patients at one general practice and found that while 70.3% of them were hitting NHS cholesterol targets, fewer than a third were reaching the new NICE targets, which match those set by the Joint British Societies.

The low rate of target achievement occurred even though 36% of patients were on lipid-lowering drugs other than simvastatin, the researchers told a British Cardiovascular Society meeting.

Professor Mike Kirby said PCTs should understand the short-term costs of intensive statin treatment would be outweighed by long-term gains.

Copyright © PA Business 2008

NICE

Comments

The policies of government of not allowing generic drugs in to market has produce a problems for patients. The company named drugs are readily available for hefty prices while generic drugs are accessible very cheap. For example, medicines with regard to sexual satisfaction aren't incorporated in to health care strategy, therefore guys have to pay for additional lot of money for this. In the event that these types of medicine is accessible inexpensive, it's great for individuals. Therefore rather than buying Pfizer's Inch The actual Viagra" , they are able to attempt universal medicines that contains tadalafil.